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Abstract
The prevalence of diabetes mellitus (DM) continues to be a global concern among health
care practitioners. Without collaboration and interventions, this chronic disease, which
poses a significant financial burden for health care institutions, will continue to be
problematic. Promoting the use of glycemic control measures among diabetic patients is
an intervention, which has the potential to reduce diabetic complications and improve
outcomes. The purpose of this doctoral project was to explore available evidence through
a systematic review of the best practices for glucose management. The chronic care
model served as the theoretical framework. The evidence based practice question was,
What is the current evidence supporting the utilization of a computer-based glucose
management system (CBGMS) for inpatient diabetic adults in acute and critical care
settings? A systematic review was conducted, yielding 532 studies in which 3 of the
studies related to CBGMSs published from 2008 to 2017 were critically appraised. The
John Hopkins Nursing Evidence Appraisal Tool with specific inclusion and exclusion
criteria was utilized. Participants were adult patients (aged 18 and over) with DM in
inpatient care settings who were English speaking. Interventions included the traditional
paper-based sliding scale regimen versus the utilization of a CBGMS. Outcome measures
included decreased length of stay, reduced cost, and glucose optimization. A conclusion
was the implementation of a CBGMS has the potential to improve patient outcomes with
additional research that exhibits overall benefits and implement into practice. Thus,
implementation of a CBGMS can lead to positive social change by aiding in a change in
practice that will ultimately ameliorate patient health outcomes.
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Section 1: Nature of the Project
Introduction
Diabetes mellitus (DM) type 1 and 2 are complex disease processes that have
affected the United States in several key ways. In 2015, there were 30.3 million
Americans, which is equivalent to 9.4% of the U.S. population, suffering from diabetes
(American Diabetes Association, 2016c). There are approximately 1.25 million children
and adults in America with type 1 diabetes (American Diabetes Association, 2016c). To
date, there are reportedly 1.5 million new cases of Americans who have been diagnosed
with diabetes yearly in the United States and the mortality rate for these individuals has
risen significantly (American Diabetes Association, 2016c). Presently, diabetes remains
the 7th leading cause of death in the United States, with 252,806 death certificates listing
DM as the underlying reason for death in the U.S. population in 2015 (American
Diabetes Association, 2016c).
The estimated total cost for individuals diagnosed with DM type 1 and 2 in the
United States rose to $245 billion in 2012 from $174 billion in 2007 (Romero, 2016).
This chronic illness poses a substantial financial burden for the United States with the
noted rise of the total cost from 2007 to 2012. The complications associated with DM
also may lead to exorbitant health care costs and medical expenditures (American
Diabetes Association, 2016a). Results of the Diabetes Control and Complications Trial
(DCCT) showed that thorough glycemic control reduces microvascular and
macrovascular complications in patients who suffer from DM type 1 and 2 (Gregg, Li,
Wang, Burrows, Ali, Rolka, Williams, & Geiss, 2014). These complications include but
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are not limited to retinopathy, nephropathy, neuropathy, ischemic heart disease,
peripheral vascular disease, and cerebrovascular disease (Gregg et al., 2014).
Thus, the use of a computer-based glucose management system (CBGMS) could
aid health care professionals in ameliorating patient care by: optimizing patients’ glucose
levels, reducing overall health care cost and medical expenditures, and decreasing
complications manifested by poor glycemic control (Mann, Jones, Wolf & Wade, 2011).
Additionally, the Centers for Medicare and Medicaid Services (CMS) have deemed the
manifestations of inadequate glucose control as a preventable error which presents a
financial burden to health care organizations (Romero, 2016). Consequently, there are
also significant risks associated with inpatient hyperglycemic and hypoglycemic events
including but not limited to increased mortality rates, longer length of stay (LOS), and an
increased risk for intensive care unit (ICU) admission (Tanenberg, Hardee, Rothermel, &
Drake, 2017).
These risks have led to efforts by health care professionals to maintain optimal
glucose control in the hospital setting. Tanenberg et al. (2017), indicated that
approximately 8% of patients that are admitted into the hospital setting will experience at
least 1 hyperglycemic or hypoglycemic event. The use of CBGMSs has also been found
to have very successful outcomes within the inpatient care population (Tanenberg et al.,
2017). CBGMSs utilize algorithms and/or clinical decision support software, which
provide therapy recommendations (Tanenberg, 2017).
There is substantial evidence supporting the utilization of a CBGMS versus the
traditional sliding scale protocol (Tanenberg, 2017). The traditional sliding scale protocol
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entails rapid-acting insulin administration to aid in rising blood glucose levels pre-meal
time and is adjusted based on the blood glucose level (Trotter, Conaway, & Burns, 2013).
The results were quite significant in a study discussed in Tanenberg et al. (2017), in
which patients who had undergone cardiac surgery with their blood glucose level
controlled with the utilization of a CBGMS were compared to patients who had their
glucose level controlled with utilization of the traditional sliding scale regimen. The
study authors found that cardiac patients who had used the CBGMS had a 2.5-fold
decrease related to post-operative complications (Tanenberg et al., 2017).
The traditional sliding scale insulin regimen has been the standard of care and the
most common strategy used to treat patients suffering from diabetes since the 1970s
(Badlani, Ford, Yu, Brogan, Pollack, & Volturo, 2014). However, treating patients solely
with this regimen has been found to be ineffective (Badlani et al., 2014). Thus, in 2006,
the American College of Endocrinology (ACE) and the American Diabetes Association
(ADA) recommended that insulin protocols, along with algorithms, and/or order sets be
used to treat hyperglycemia and hypoglycemia events in the inpatient hospital care setting
(Tanenberg et al., 2017). The aim of this DNP project was to conduct a systematic review
of the literature on the use of CBGMSs for inpatient adults.
Problem Statement
Despite the progress and advancements of CBGMS, many organizations and
health care providers are reluctant to consider these systems to aid in caring for their
patients (Mann, et al., 2011). There are several reasons accounting for health care
providers’ reluctance in adopting CBGMSs. Some of the reasons include (a) lack of Food
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and Drug Administration (FDA) approval for insulin dosing in the United States; (b) cost
and reimbursement issues; (c) the recalibration requirement for the systems; (d) training
time and the cost for health care professionals who care for diabetic patients within an
organization; (e) lack of standardization in available software; (f) the need for more
clinical practice guidelines regarding the role of CBGMS; and (g) the need for the clinical
research to be disseminated to all health care organizations and professionals to aid in
determining best practice (Rodbard, 2016).
The common practice of providers utilizing standard protocols and sliding scale
glucose management alone has proven to be ineffectual over time (Mann, Allen, SerioMelvin, Wolf, & Salinas, 2012). Health care organizations and providers are being held
to a higher standard when caring for diabetic patients. This higher standard of care is
recommended and supported by the American Diabetes Association. The American
Diabetes Association (2016) recommends that health care organizations and providers
use a patient-centeredness approach when caring for diabetic patients. This means that
health care organizations and providers must provide a comprehensive plan of care for
diabetic patients to aid in addressing and reducing complications (American Diabetes
Association, 2016). Health care organizations and providers must also have a sound care
team (American Diabetes Association, 2016b). This care team includes but is not limited
to the primary care provider, diabetic educator, registered dietician, endocrinologist,
ophthalmologist, social worker, podiatrist, pharmacist, dentist, and family members or
caregivers (American Diabetes Association, 2016b). Moreover, the American Diabetes
Association recommends the utilization of decision support tools to aid in meeting
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diabetic patient needs (American Diabetes Association, 2016). CBGMSs are considered a
decision support tool.
CBGMSs integrate software that utilizes point of care glucose levels to determine
the appropriate insulin needed to achieve the desired glucose range (Mann et al., 2012).
According to Mann et al. (2012), undesirable outcomes for diabetic patients could
continue until health care organizations and providers are willing to enhance their
knowledge base and contemplate adopting an assistive computer-based decision support
system. Researching best practices related to glucose management and disseminating this
research to health care professionals, could aid in the use of CBGMS for diabetics in the
inpatient care setting. In developing this systematic review of evidence, I wanted to aid in
closing the research-practice gap and provide the evidence necessary to support the
adoption of CBGMSs for managing diabetics in the inpatient care setting. Adopting
CBGMS could aid in improving patient outcomes, safety, and quality of care and
reducing mortality (Crockett et al., 2012).
Purpose
Identifying evidence regarding the utilization of a CBGMS for the management of
glucose levels for inpatient adults was the purpose for this systematic review. I used the
Johns Hopkins Nursing Evidence-Based Practice Levels of Evidence tools for this
systematic review (see Appendix D and E). The Johns Hopkins Nursing Evidence-Based
Practice: Levels of Evidence systematic review is used to analyze RCTs (randomized
controlled trials) and quasi-experimental studies with or without-meta analysis or
synthesis (John Hopkins Medicine Center for Evidence Based Practice 2017). Non-
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experimental studies, opinions from respected authorities, literature reviews, and case
reports are also analyzed (John Hopkins Medicine Center for Evidence Based Practice
2017).
The organization in which I completed my DNP practicum experience hours hired
an inpatient diabetic coordinator (IDC) in early 2016. Since the hiring of the IDC, the
organization has been seeking ways to improve the care provided to its adult inpatient
diabetic population. The new IDC developed a diabetes management program (DMP) and
created a diabetes steering committee (DSC). It was decided by myself to conduct
research and perform a systematic review for the committee on the benefits of the
utilization of a CBGMS. This was decided because the organization’s sister facility was
utilizing a system called EndoTool which is a CBGMS. According to an official at the
practicum site, EndoTool has improved the sister facility’s outcomes, and the
organization could benefit from a systematic review on CBGMSs.
A systematic review was conducted and carried out prospectively and
comprehensively. This review was structured utilizing the Johns Hopkins Nursing
Evidence-Based Practice Project Management Guide (see Appendix B). There were a
total of 18 steps that could be used to carry out a project utilizing the Johns Hopkins
Nursing Evidence-Based Practice Project Management Guide. However, this project was
a systematic review, for which the pertinent steps were 1 through 11, 16, 17, and 18 (see
Appendix B). Step 12 was eliminated because it requires an action plan. This is a
systematic review that will be presented to the IDC and the DSC, and an action plan is
not required. Step 13 was eliminated because it requires support and resources to
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implement the action plan and there is no action plan needed for this systematic review
and the method of dissemination. Step 14 was eliminated because it requires the
implementation of the action plan and this is not required for this systematic review. Step
15 was eliminated because it requires evaluation of outcomes. This is a systematic review
that will be presented to the IDC and DSC and the decision to adopt a CBGMS will
solely rely on their decision.
I drew from the Johns Hopkins Nursing Evidence-Based Practice Question
Development Tool (see Appendix C) in developing the evidence-based practice question
developed for this systematic review. The evidence based practice question for this
systematic review was, What is the current evidence supporting the utilization of a
CBGMS for inpatient diabetic adults in acute and critical care settings?
Nature of the Doctoral Project
In conducing this review, I explored the available evidence following a systematic
format. A systematic review is defined as a “review of a clearly formulated question that
uses systematic and explicit methods to identify, select, and critically appraise relevant
research” (Ham-Baloyi & Jordan, 2016, p. 122). According to Gough, Oliver, and
Thomas (2012), researchers performing systematic reviews use explicit, rigorous, and
accountable methods to identify gaps in existing literature.
This review was conducted by accessing databases such as CINAHL Plus with
Full Text, MEDLINE with Full Text, and Cochrane Systematic Reviews. Search
methodology, terms, and results are discussed in detail in Section 3. This systematic
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review provides a summary of the available evidence to support further decision making
in acute and critical care settings to help narrow the knowledge-practice gap.
Significance
Traditional sliding-scale insulin has widely been utilized and deemed the
treatment of choice for an extended timeframe for health care professionals in their daily
practice (Guthrie, Hinnen, & Childs, 2011). Despite the wide acceptance of the utilization
of traditional sliding-scale insulin and glycemic control for those experiencing
hypoglycemia or hyperglycemia, there is little evidence supporting its efficacy (Guthrie
et al., 2011). There are potential complications associated with using the traditional
sliding scale regimen for glycemic control for episodes of hypoglycemia and
hyperglycemia (Guthrie et al., 2011). Traditional sliding scale insulin has also been
linked to an increased fluctuation of blood glucose levels (Guthrie et al., 2011).
Moreover, the fluctuation of blood glucose levels is viewed as unfavorable to patients
physiologically (Guthrie et al., 2011).
The American Diabetes Association (ADA) also plays an integral role in diabetes
care and management in the United States. It is the ADA’s recommendation to increase
the quantity of individualized care provided in the treatment of those with DM (American
Diabetes Association, 2013). The individualized care includes an individualized care plan
and a road map that will outline goals specific to the patient needs. This recommendation
has been revised and published in the January 2014 issue of Diabetes Care for Standards
of Medical Care (American Diabetes Association, 2013). Moreover, this recommendation
encourages health care professionals to examine an array of options and not solely the
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traditional methods of treatment. In conducting this review, I sought to appraise the
current body of evidence to discern if there is enough evidence available to prospectively
work towards translating the concept of utilization of CBGMS into practice. The
identified stakeholders for this review were providers and affected patients with DM type
1 or 2.
Summary
The purpose of Section 1 was to provide background information based on the
systematic review. This included the review question, purpose of the study, and nature of
the study. The introduction in this section provided the background information into the
project and the thought process on why it is vital to practice appropriate glucose
management for inpatient adults in acute and critical care settings. The utilization of a
CBGMS in the electronic health record (EHR) has been found to ameliorate diabetics’
outcomes during hospitalization (Tanenberg et al., 2017). A change in the way that health
care organizations provide treatment to patients with DM can advance the organizations
knowledge and optimize the quality of care delivered. Properly managing patients’
glucose level is deficient in many health care organizations in the United States (Romero,
2016). If DM is not managed appropriately, it may lead to an increase in inpatient
population admissions, re-admissions, mortality rates, morbidity rates, diabetic
complications, health care expenditures, and barriers to proper treatment (Gregg et al.,
2014).
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Section 2: Background and Context
Introduction
Computer decision glucose management support systems ameliorate patient care
by comparing distinctive characteristics with a sound knowledge base providing
customized clinical recommendations (Gillaizeau et al., 2013). According to Gillaizeau et
al. (2013), “ideally, decision support, integrated in the electronic medical record as the
platform, can provide physicians with tools making it possible to improve practice and
patient safety” (p. 8). An effective computer decision support glucose management
system can aid health care professionals in predicting patients’ specific needs and
promptly conveying information (Gillaizeau et al., 2013). CBGMSs can aid health care
professionals in ameliorating patient outcomes more frequently than the traditional paperbased insulin titration regimen it substitutes, while accomplishing significantly fewer
hypoglycemic episodes (Mann et al., 2012).
Concepts, Models, and Theories
Glucose management is an integral component of nursing care. Preventing
adverse outcomes and treating glucose levels in inpatient adults should take precedence
when caring for diabetic patients (American Diabetes Association, 2016b). The chronic
care model (CCM) served as the theoretical framework for my systematic review the use
of a CBGMS with inpatient adults in acute and chronic care settings. The CCM employs
a systematic approach with a combination of components (Stellefson, Dipnarine, &
Stopka, 2013). According to Stellefson et al. (2013), this model utilizes “decision-support
components to train providers on guidelines for American Diabetes Association (ADA)
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Standards of Care” (p. 21). This model also utilizes a system design component to aid in
remodeling the care delivery process to provide self-management support through
diabetes self-management education (DSME) (Stellefson et al., 2013). The combination
of components utilized to promote optimized quality chronic disease care includes the
community, the health system, self-management delivery system design, decision support
and clinical information systems (The Chronic Care Model, 2017). Each component has
evidence-based change concepts linked to it. Together, the components and elements of
the CCM foster valuable interactions between the patient and the health care professional
(The Chronic Care Model, 2017). These elements include patient safety (the health
system), cultural competency (the self-management delivery system design), care
coordination (the health system and clinical information systems), community policies
(the community resources and policy), and case management (in the self-management
delivery system design; The Chronic Care Model, 2017).
There is evidence showing that use of the CCM effectively improves the health of
diabetic patients, with positive outcomes well documented in several studies (Stellefson
et al., 2013; see Figure I1). Similarly, the American Diabetes Association (2016)
recommends that care be aligned with the components of the CCM. The Association
made the recommendation to “ensure productive interactions between a prepared,
proactive practice team and an informed, activated patient” (American Diabetes
Association, 2016, p. 1). The CCM model also aids health care professionals in
facilitating patients’ self-management by supporting patient behavior change and
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providing a coordinated care team to aid in optimal diabetes management (American
Diabetes Association, 2016).
The evidence-based practice question I sought to answer concerned whether there
is a sufficient quantity of evidence to support the utilization of a CBGMS, on the basis
that this type of system can prospectively yield positive results and improve glucose
levels with inpatient adults. Diabetes can cause many adverse outcomes including
increased length of stay in the hospital and microvascular and macrovascular
complications (Romero, 2016). For these reasons, it is important that health care
professionals seek out systems or processes that can bestow positive outcomes for
patients and health care organizations.
Relevance to Nursing Practice
Health care professionals around the United States strain to stabilize managing
DM due to the many existing challenges and barriers in the practice setting (Crockett et
al., 2012). It is estimated that DM affects 24 million Americans a year, which makes this
illness one of the most chronic diseases in the United States (Miller & Dimatteo, 2013).
The number of DM diagnoses is expected to double by 2034 (Miller & Dimatteo, 2013).
Diabetes has been linked to “heart disease, stroke, kidney failure, lower limb amputation,
and blindness” (Miller & Dimatteo, 2013, p. 422).
Diabetic patients must adhere to strict treatment such as medication including
insulin injections, self-monitoring of blood glucose levels, strict dietary changes, frequent
vision examinations, and daily exercise routines (Miller & Dimatteo, 2013). The strict
treatment regimen that patients suffering from DM follow, makes it imperative for nurses
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to provide adequate glucose management for all inpatient diabetic patients in the acute
and critical care setting. For a number of years, health care organizations around the
United States have provided the standard traditional sliding scale insulin regimen (Mann
et al., 2012) to patients with DM. There is evidence supporting the expansion of the
traditional practice of glucose management in acute and critical care settings (Mann et al.,
2012). However, according to my review of the literature, little has been done to translate
the evidence into practice.
The U.S. public’s opinion is assessed by the Gallup poll annually. The Gallup poll
measures issues that matter to the society which includes but not limited personal safety,
well-being, and confidence in national institutions such as health care organization
(Gallup, 2017). For 13 plus years, the results of the Gallup poll have shown that
Americans rate nursing “as the most honest profession and nurses as having the highest
ethical standards” (Winland-Brown, Lachman, & Swanson, 2015, p.268). The American
Nurses Association’s (ANA) Code of Ethics is comprised of nine provisions (WinlandBrown et al., 2015). The first three provisions explain the most essential merits, values,
and commitments for a practicing nurse (Winland-Brown et al., 2015). Also, the first
three provisions address nursing duties, how patients should be respected, and the need
for consideration of social and economic status, personal attributes, and the nature of
health problems (Windland-Brown et al., 2015). The fourth provision addresses how a
nurse should be held accountable in day-to-day practice (Winland-Brown et al., 2015).
Provisions 5 and 6 of the ANA Code of Ethics primarily focus on do’s and don’ts
of nursing duties and issues of loyalty (Lachman, Swanson, & Windland-Brown, 2015).
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Similarly, Provisions 7 through 9 focus on nurses’ ethical duties. However, these
provisions support the notion that nurses are obligated to be directly involved in health
policy as well as responsible to contributing nursing knowledge through scholarly inquiry
and research (Lachman et al., 2015). With all of this noted, it is a nurse’s sworn duty to
ensure that all patients are cared for optimally and in a safe manner, and to stay current
on evidence regarding best practices (Lachman et al., 2015). By providing an alternative
way to manage glucose levels for inpatients, nurses can promote and advocate for the
rights and overall health of their patients and provide safe care. Hence, the utilization of a
CBGMS to care for inpatient diabetic patients is pertinent to nursing practice in acute and
critical care settings.
Local Background and Context
The practicum site of this DNP student is a full service acute-care facility in the
local area. The facility has over 1,600 employees and over 1,000 physicians employed,
with over 70 specialties and subspecialties (Medical City Plano, 2017). Overall the
facility has a capacity of 493 beds and are in the process of building another inpatient
unit. The review question was identified by myself during patient rounding on the
Neuroscience Progressive Care Unit (NSPCU) and with the Inpatient Diabetes
Coordinator (IDC). I have a nursing background with experience in caring for adults with
diabetes mellitus. During my research on diabetes management, I discovered several
different computerized clinical decision support systems for treatment of hyperglycemic
and hypoglycemic episodes. I am an active member of the diabetes steering committee
(DSC) within the practicum site. When asked about the possible utilization of a CBGMS,
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the diabetes steering committee members noted that they have heard of a CBGMS called
EndoTool. They stated that one of their sister facility utilizes it. The committee members
stated that to their knowledge, there is not enough sufficient evidence to support the
utilization of a CBGMS (S. Harris, personal communication, September 15, 2016).
Moreover, the members also stated that the cost associated with the software that is
needed to be integrated into the EHR was too expensive to even consider. This prompted
the need for further investigation on my part and the formulation of the review question
to present to the diabetes steering committee (DSC).
Role of the DNP Student
The essential skills of a DNP prepared nurse bestow collaboration and utilization
of leadership skills to “improve patient outcomes, the creation of new collaborative care
delivery models that will meet the increasing demand for services, and the development
of policy to enhance services and remove practice barriers” (Houghton, Casal, Fortuna, &
Larsen, 2015, p.13). As a Doctor of Nursing Practice (DNP) prepared student, my role in
this project is to integrate knowledge acquired through my studies and exhibit
representation of clinical evidence of CBGMSs to optimize clinical outcomes. This also
entailed conducting a systematic review of literature on the review question.
Summary
Section 2 provided background and context information on CBGMSs and how the
utilization of these systems can ameliorate patient care and patient outcomes. The clinical
recommendations by the American Diabetes Association were also discussed in this
section which aids in validating the feasibility and probability of the utilization of
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CBGMSs. The CCM was identified as the appropriate theoretical framework for the DNP
project in this section. The key components and elements that are encompassed within the
CCM aid in optimizing patient outcomes not only in the inpatient care setting but also
aids in self-management and behavior changes. The relevance to nursing practice, the
local background and context of the practicum site, which noted the number of
employees, specialists, sub-specialists, and bed capacity, provided details as to why and
how adopting a CBGMS is relevant to current nursing practice. Lastly, the role of the
DNP student was discussed in detail with emphasis on applying knowledge obtained
through studies, collaborating with the DSC and IDC, and conducting a systematic
review to support the adoption of a CBGMS for the practicum site.
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Section 3: Collection and Analysis of Evidence
Executive Summary
Background
Diabetes is the seventh leading cause of death in the United States (American
Diabetes Association, 2016). Total costs of diagnosed diabetes are $245 billion annually,
$176 billion for direct medical costs, and $69 billion in reduced productivity (American
Diabetes Association, 2016). Without collaboration and interventions by health care
professionals, the cost and numbers will continue to increase. Researchers have found
that patients with DM type 1 and 2 who receive assistance from health care professionals
with glycemic control measures show reduced microvascular and macrovascular
complications (American Diabetes Association, 2016b). Despite the evidence exhibiting
the advantages of tighter glycemic control within the inpatient adult population group
there have been minimal efforts to translate the evidence into practice (Tanenberg et al.
2017).
This systematic review explored the evidence available on adult patients (those
aged 18 and older) with type 1 or type 2 diabetes who are managed with the traditional
sliding scale insulin protocol versus a CBGMS in acute and critical care settings. A future
review would be beneficial to study the efficacy of a clinical decision support tool with a
narrower age range. Glucose fluctuations have been found to contribute to adverse
outcomes for patients in the inpatient population (Blair, Zamora, Brumbelow, & Mercer,
2012). These fluctuations increase the mortality, morbidity, and length of stay in the
hospital (Blair et al., 2012). Use of a computerized clinical decision support tool which
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incorporates a software that is integrated into the EHR could aid in improving patient
outcomes, reducing the financial burden faced by health care organizations, and
decreasing patients’ LOS (Blair et al., 2012).
The chronic care model (CCM) served as the theoretical framework for my
project study of use of computerized clinical decision support systems for inpatient
diabetic adults in acute and critical care settings (The Chronic Care Model, 2017). This
model is comprised of decision support components that are used by health care
professionals in providing optimal care for those suffering from a chronic illness such as
DM (The Chronic Care Model, 2017). A literature review was performed with specific
inclusion and exclusion criteria. The articles were appraised using the John Hopkins
Nursing Evidence-Based Practice Research Evidence Appraisal Tool as a guide for
qualitative studies (John Hopkins Medicine Center for Evidence Based Practice, 2017).
Each article was categorized by level of evidence and quality rating. Results of my
project analysis aided in supporting the utilization of a computerized clinical decision
support tool and provided evidence of the need for future studies to narrow the gap in
knowledge and practice. I received confirmation from the Walden’s University
Institutional Review Board (IRB) to collect and analyze data from public reports and
published literature on July 7, 2017. The IRB approval number is 07-07-17-0496733.
Objectives
The evidence based practice question was, What is the current evidence
supporting the utilization of a CBGMS for inpatient diabetic adults in the acute and
critical care settings?
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Inclusion Criteria and Exclusion Criteria
Type of participants. This review included studies of adult patients, who were
aged 18 and over and who spoke the English language, and were in the inpatient setting
with type 1 or type 2 DM, where they were using the traditional paper-based sliding scale
method versus a CBGMS. Articles excluded were studies done on infants, children 4
years of age or older, toddlers 12 to 36 months old, neonates under 28 days old, or adults
less than 18 years of age, and any article written in a language other than English. The
search was limited by years. A majority of the research was conducted over the past 7
years, with the landmark study occurring 9 years ago in 2008. All duplicates have been
removed.
Type of intervention. This review included studies in which the traditional
paper-based sliding scale glucose management regimen was compared to the utilization
of a CBGMS.
Types of outcomes.
This review included studies examining the following outcome measures:
decreased length of stay, reduced cost, optimized hyperglycemic, and hypoglycemic
episodes.
Types of studies.
This review included systematic reviews from multiple other studies with metaanalysis of RCTs, which studied inpatient adults treated with the traditional paper-based
glucose regimen compared to a CBGMS. Cohort studies (prospective observational
studies), systematic reviews without meta- analysis or synthesis, and quasi-experimental
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studies were considered only in the absence of systematic reviews with meta-analysis or
synthesis.
Search Strategy
The search strategy included both published and unpublished studies. A three-step
search strategy was used in this review. An initial limited search of CINAHL,
MEDLINE, and Cochrane was utilized followed by an analysis of the keywords
contained in the title, abstract, and the index terms used to describe the article. A second
search utilized all identified keywords and indexed terms to assess all included databases.
Thirdly, the reference list of all relevant articles was searched for additional studies.
Studies published or translated into English were considered for inclusion in this review.
To remain consistent with the current technology of CBGMS, studies published between
2008 and 2017 were considered for inclusion in this review. The databases included in
the search were the following:
•

CINAHL Plus with Full Text,

•

MEDLINE with Full Text,

•

Cochrane Database of Systematic Reviews,

•

Ovid Nursing Journals Full Text,

•

PubMed,

•

Health Technology Assessments,

•

ProQuest Central,

•

Joanna Briggs Institute (JBI) Database of Evidence Based Practice,

•

Web of Science,

21
•

PsycINFO,

•

Thoreau Multi-Database Search, and

•

Academic Search Complete.

I also made an effort to identify literature that may not have been published. I searched
for unpublished studies on the search engine Google Scholar and on the websites of the
following organizations: American Diabetes Association, American Association of
Clinical Endocrinologists, American College of Endocrinology, and International
Diabetes Federation.
Initial keywords included the following: type 1 diabetes, type 2 diabetes, adults,
computer-based glucose management systems, computer glucose management systems,
glucose management, acute care setting, critical care setting, traditional insulin sliding
scale AND disadvantages, computer based AND glucose management, computer based
glucose management system AND critical care, computerized glucose management
systems, computer based glucose management AND acute care, and computer based
glucose management algorithms. A detailed individual evidence summary tool/table was
maintained. Please see Appendix F for a visual representation.
Methodological quality. Papers selected for retrieval were assessed by one
independent reviewer for methodological validity utilizing a standardized critical
appraisal instrument from the Johns Hopkins Nursing Evidence-Based Practice Research
Appraisal Tool. The independent reviewer possesses a Master’s of Science degree in
nursing, with a specialty in Healthcare Systems Management. Likewise, the reviewer has
also completed all course work for the Doctor of Nursing Practice terminal degree. The
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Johns Hopkins Evidence Level and Quality Guide were utilized as a guide to aid in the
grading level and quality of all papers received (Appendix D).
Method of the Review
After completing the search for studies and the study selection process, there were
an abundance of studies collected but none that met the specific inclusion criteria for the
review, which was determined to be too narrow. To aid in capturing more relevant data to
answer the evidence based question, there was a decision made to deviate from the
original protocol. Initially, the protocol intended to evaluate keywords: type 1 diabetes,
type 2 diabetes, adults, computer-based glucose management systems, computer glucose
management systems, glucose management, acute care setting, critical care setting,
traditional insulin sliding scale AND disadvantages, computer based AND glucose
management, computer based glucose management system AND critical care, computer
based glucose management AND acute care, and computer based glucose management
algorithms. However, the inclusion criteria was amended to include clinical decision
support glucose management systems in order to capture all relevant data.
Critical Appraisal
The studies selected for retrieval were assessed by one independent reviewer for
methodological validity prior to inclusion in the review utilizing a standardized critical
appraisal instrument from the Johns Hopkins Nursing Evidence-Based Practice Research
Evidence Appraisal Tool (Appendix E). The independent reviewer possesses a Master’s
of Science degree in nursing, with a specialty in Healthcare Systems Management.
Likewise, the reviewer has also completed all course work for the Doctor of Nursing
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Practice terminal degree. With only one reviewer, gaining a consensus regarding the
research assessment was not available and thus risked bias. Studies included required
positive responses to questions number 1 through 15 of the Johns Hopkins Quality
Appraisal of Research Studies and questions 1 through 12 of the Johns Hopkins Quality
Appraisal of Systematic Review with or without Meta-Analysis or Meta-Synthesis
(Appendix E).
Data Extraction
Data was extracted from studies included in the review utilizing the standardized
data extraction tool from Johns Hopkins Nursing Evidence-Based Practice Appraisal
Tool (Appendix E). The data extracted encompassed explicit details about the
interventions, populations, study methods and outcomes of significance to the evidence
based practice question and the specific objectives.
Data Synthesis
Data synthesis was assisted by the utilization of the Johns Hopkins Nursing
Evidence-Based Practice Synthesis of Evidence Guide and Recommendation Tool
(Figure I2).
Results
The initial literature search results included approximately 532 studies of which
each title was reviewed. From those titles, 177 articles were determined to be potentially
relevant studies. Upon review of the abstracts, 158 articles were excluded from the
review. Exclusion was due to age of the participants, pediatrics, different disease
processes, telemedicine, smartphone decision support, different outcome measures
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including study focus on hemoglobin A1c levels, diet, exercise, self-management, nonsystematic review randomized control trials (RCTs), or non-qualitative outcomes
measures. The remaining 19 articles were reviewed in their entirety. All were excluded
because they did not meet the inclusion criteria of: adult patients, speaking the English
language, aged 18 and over, in the inpatient setting with type 1 or type 2 diabetes mellitus
utilizing the traditional paper-based sliding scale method versus a computer-based
glucose management system. The primary outcomes of the studies were different, or the
study was not a systematic review randomized control trial with meta-analysis. Following
the decision to amend the inclusion criteria to include clinical decision support glucose
management systems a second review was conducted. After the second review of the full
papers, a total of 16 papers were excluded. (Appendix G). This resulted in three papers,
which met the inclusion criteria and were critically appraised by the reviewer. (Figure
I3).
Conclusions
From the findings in the review, the implementation of a computer-based glucose
management system versus the traditional paper-based sliding scale regimen has the
potential to improve patient outcomes but more research studies are needed to validate its
overall benefits.
Implication for Practice
The systematic review supported the initiative to, at the minimum, consider
adopting a computer-based glucose management system in the inpatient care setting.
Since the practicum site has not implemented any type of computer-based glucose
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management system, a systematic review was conducted to address that need. During the
systematic review, it was discovered that a sister facility of the organization had already
adopted a computer-based glucose management system called EndoTool and the software
was already integrated into their EHR system. The success of the systematic review in
providing knowledge on best practices when caring for inpatient diabetes should increase
the capability for healthcare professionals to optimize inpatient diabetic outcomes. The
systematic review will be presented to the Diabetes Steering Committee (DSC) and the
Inpatient Diabetic Coordinator (IDC), if approved for implementation the system can be
adopted and mirror the practicum sites sister facility.
Implication for Research
There are several significant implications for future research. Ongoing research
regarding the safety, efficacy, and effectiveness of computer-based glucose management
systems should be at the forefront. Education that aids the practicum site in (a) training;
(b) obtaining the skill-set to care for patients through the assistance of a computerized
management system; and (c) education on maintenance of the system should also be
ongoing if the decision is to adopt the system. There should be an ongoing assessment of
the healthcare professionals (a) knowledge; (b) skillset; and (c) confidence in caring for
the inpatient diabetic patients.
Completion of the systematic review does suggest that there are benefits to
computer-based management systems in general. Some of the benefits are (a) a
therapeutic range could be reached and maintained; (b) it spearheads to an optimized
physiological parameter more frequently; (c) it aids in ameliorating stabilization of
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medications quicker; and (d) it is predicted to ultimately reduces the length of stay (LOS)
and is cost-effective (Gillaizeau et al., 2013). However, with this information presented,
it is imperative to continue research to validate the validity and feasibility of a computerbased glucose management system.
Keywords
Type 1 diabetes, type 2 diabetes, adults, computer-based glucose management
systems, computer glucose management systems, glucose management, acute care
setting, critical care setting, traditional insulin sliding scale AND disadvantages,
computer based AND glucose management, computer based glucose management system
AND critical care, computer based glucose management AND acute care, computer
based glucose management algorithms and clinical decision support glucose management
systems.
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Section 4: Findings and Recommendations
Findings and Implications
The Johns Hopkins Nursing Evidence-Based Practice Research Appraisal Tool
(see Appendix E) and the Johns Hopkins Nursing Evidence-Based Practice Evidence
Level and Quality Guide (see Appendix D) were used to evaluate and appraise the
strength of the data extracted from all three research articles. All scientific data extracted
went through a rigorous process, wherein I first appraised the level of evidence which is
the study design, the quality of research studies, and the quality of systematic review with
or without meta-analysis or meta synthesis and, then, surmised the quality rating based
upon the quality appraisal. All three studies were systematic reviews of multiple other
studies with meta-analysis of randomized controlled trials.
The three studies included 30 plus RCTs. Data were extracted from several
different scientific databases including Cochrane Central Register of Controlled Trials
(CENTRAL), MEDLINE, PubMed, Ovid, EMBASE, Psych INFO, Web of Science,
ASLIB Index to Theses, ProQuest Digital Dissertations and Theses, and CINAHL. All
studies were full-text articles. All subjects were diagnosed with type 1 or type 2 DM and
were over the age of 18. Fillmore, Bray, & Kawamoto (2013) was updated for a strategy
search adapted from previous systematic reviews in 2013. Gillaizeau, et al. (2013) was
updated earlier by the Cochrane systematic reviews which were first published in 2001
and updated in 2008. Nieuwlaat et al. (2011) was updated with new studies in January
2010 from MEDLINE, EMBASE, Evidence-Based Medicine Reviews, and Inspec
databases. In all three studies, the participants were health care professionals who were
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responsible for patient care. Data were extracted from RCTs, nonrandomized controlled
trials (NRCTs), controlled before-after studies (CBA), and interrupted-time series (ITs).
However, for this systematic review, I decided to focus on RCTs with meta-analysis were
analyzed. There were two reviewers for each systematic review. For each study, a
flowchart was used to show how articles were managed during the analysis.
The researcher in all three studies identified what was known and/or not known
and whether further research is needed to address any knowledge gaps. The purpose of
each study was clearly presented. All literature reviewed was current with most sources
within a 5-year timeframe from date of publication. With all control groups, the
characteristics and demographics were similar and the interventions were the same to
validate the feasibility of a CBGMS versus the traditional paper protocol. The researchers
of all studies used reliable instruments to validate the research question or hypotheses.
All results were presented clearly for the reviewer to interpret. The tables, diagrams, and
figures included in all three studies entailed a narrative to explain content. In all three
studies, limitations and how these limitations could be addressed were discussed. The
reviewer also identified other limitations (see Appendix F). All three studies presented
conclusions based off the results from their findings. The background information
presented in all three studies discussed the purpose for the systematic review. All three
studies included keywords or key terms and inclusion criteria that also matched the
reviewer inclusive inclusion criteria list. All pertinent details were included in each study;
these included design, sample size, methods utilized to extract data, results, strengths of
the data extracted, limitations of the data extracted, and recommendations. To some
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degree, the authors of each study appraised the evidence by stating whether the evidence
was of high, good, or low quality.
Assessment of Methodological Quality
The three studies selected for assessment of methodological quality were
evaluated by one independent reviewer for methodological validity prior to inclusion in
the review using a standardized critical appraisal methodology, the Johns Hopkins
Nursing Evidence-Based Practice Research Evidence Appraisal Tool (see Appendix E).
Based on an independent review prior to the appraisal process,
I decided a positive response was required to Items 1 through 15 of the Johns
Hopkins Quality Appraisal of Research Studies and Questions 1 through 12 of the Johns
Hopkins Quality Analysis of Systematic Review with or without meta-analysis or metasynthesis. However, following detailed review, all relevant assessment questions were
addressed. Based on methodological quality assessment, three studies were included in
the review (see Table 1).
Table 1
Number of Studies Included and Excluded in the Project Study
Number of studies included

Number of studies excluded

3

16

Detailed Discussion of Findings
Fillmore et al. (2013). Fillmore et al. (2013) is an evidence level I, quality level
B RCT with meta-analysis. The authors described increasing health care costs, how

30
inpatient hospitalizations are the driving force for this increase, and how clinical decision
support systems could aid in improving these issues (Fillmore et al., 2013). The findings
in this systematic review exhibited that clinical decision support (CDS) systems are an
optimizing approach to ameliorating care and reducing cost in inpatient care settings. The
purpose of the Fillmore et al. (2013) systematic review was to analyze trials using CDS
systems interventions that had the possibility of reducing inpatient care costs.
Fillmore et al. (2013) searched and retrieved 7,663 articles and 78 manuscripts,
78.2% of which were controlled before-after studies, and 15.4% of which were RCTs.
Most of the manuscripts were published during the years 2008 and thereafter. Moreover,
7,500 references were excluded after screening of titles and abstracts. A total of 163 fulltext articles were deemed potentials per Fillmore et al (2013), of which 78 met the criteria
for inclusion for the review. A total of 70.5% of the studies exhibited clinical
amelioration through financial and proxy financial measures (Fillmore et al., 2013).
However, the actual financial impact was not measured adequately, and the researchers
encouraged further research.
The search strategy to retrieve articles included only MEDLINE through July 18,
2013 (Fillmore et al., 2013). The following search terms were included: decision support
systems, clinical; decision-making, computer-assisted; computerized decision support;
reminder systems; guideline adherence; and medical informatics (Fillmore et al., 2013).
The inclusion, exclusion, and objective criteria included clinical decision support systems
in an inpatient setting, cost reduction, and decrease in length of stay. Exclusion criteria
that specifically matched the reviewers’ exclusion criteria were non-English studies. The
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study selection was similar to the reviewers with the titles and abstracts being evaluated
by a single reviewer which aided in determining inclusion eligibility. All studies where
data were extracted was full text. The trials that were extracted entailed outcomes that
presented potential cost saving if a clinical decision support system was adopted. The
Fisher’s exact test of independence was used to aid in the proxy cost measure. This test
was used due to the two variables, cost and study setting. Fillmore et al (2013), Authors
determined that a p-value of < 0.05 was significant. The proxy cost measures included
length of stay, re-admissions rates, resource utilization metrics such as imaging studies,
adverse events that may occur, and different process measures (Fillmore et al., 2013).
Fifty-five (70.5%) of the studies reported a statistically and clinically significant
improvement in a cost or proxy measure (Fillmore et al., 2013).
It was concluded by Fillmore et al (2013), that CDS systems do represent a
favorable approach to decrease inpatient care cost. This study did determine that there
were benefits to adopting a CDS system to aid in reduction of inpatient care costs versus
the traditional paper sliding scale insulin protocol. The researchers also mentioned that
there is more research encouraged to support CDS and inpatient care cost. There is also a
significant gap in research studies to show how CDS can reduce inpatient care cost
indefinitely.
Gillaizeau et al. (2013). Gillaizeau et al. (2013), evidence level I quality level A
randomized control trial with meta-analysis paper described how physicians and other
healthcare professionals frequently prescribe medications that only work during certain
times and not consistently working always. This paper was a systematic review on how
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these drugs are prescribed, the efficacy of the therapeutic index (TI), how it causes a
therapeutic effect, and for how long the therapeutic effect lasts. This paper made a critical
point in expressing how calculating and prescribing of medication can be very
cumbersome for healthcare professionals in general. The paper went on to express how
ascertaining the correct dosage is critical to the patients’ overall outcomes. The following
databases were included to retrieve articles for the systematic review: EPOC Group
Specialized Register, Reference Manager; Cochrane Central Register of Controlled Trials
(CENTRAL), MEDLINE, Ovid; EMBASE, Ovid; and CINAHL, and EbscoHost
(Gillaizeau et al., 2013). Another search was conducted from January 2012 to January
2013 and were placed on the Studies Awaiting Classification. The reviewers of this
review also searched the reference lists from other relevant studies from the studies they
chose to analyze. This systematic review utilized a reference manger called reference
manger 5 to aid in removing all duplicates. The authors reviewed the titles and abstracts
first then excluded studies that were not pertinent. All studies included were full text
studies which were screened by the reviewers. All extracted data was reviewed by the
reviewers independently. They could come to a consensus by having a group discussion
with four other review authors (Gillaizeau et al., 2013).
The authors reviewed previous data abstraction and developed a checklist that
aided in extracting decision support technical features such as: was the computerized
advice given in real time or delayed or was dose recommendation given (Gillaizeau et al.,
2013). Bias was assessed in this review. This was guided by EPOC Risk for Bias
checklist (Appendix H). Two authors examined the quality of evidence for each outcome
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for the review ranking: high, moderate, low, or very low. A risk ratio was also utilized.
This ratio was utilized to determine the probability of a hypoglycemic or hyperglycemic
occurring. A standardized mean difference (SMD) with a 95% confidence interval (CI)
was also utilized. The SMD measures the impact of the adverse event (diabetes crisis).
The outcomes that were measured include: “proportion of participants or time for which
the plasma drug concentrations was within the therapeutic range, proportion of
participants or time for which the studied physiological parameter was maintained within
the target range, time to achieve therapeutic control, proportion of participants with toxic
drug levels, proportion of participants with clinical improvement, proportion of
participants with adverse effects of drug therapy, proportion of deaths, length of hospital
stay, and total cost per participant” (Gillaizeau et al., 2013, p.9).
There were 42 trials with 40 randomized trials. The 42 trials were reported in 53
references (Gillaizeau et al., 2013). There was a decision to include 2 other computerassisted dosage programs as subgroup analyses (Gillaizeau et al., 2013). The 40
randomized trials where individuals who were chosen at random to receive therapy
through a computer-based protocol and 2 were non-randomized controlled trials where
the participant were chosen before the intervention was carried out. The reviewers
excluded 143 of 199 full text articles because inclusion criteria were not met. The
systematic review did not only specifically focus on computer-based systems for glucose
management, this review also included: aminoglycoside antibiotics, oral anticoagulants,
insulin, anesthetic agents, anti-rejection drugs, and antidepressants (Gillaizeau et al.,
2013). The studies utilized well-grounded outcomes measures such as: proportion of
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participants with clinical amelioration, time for attaining a therapeutic effect, quantity of
participants that experienced an unfavorable effect from the drug therapy, length of
hospital stays, and the total direct and indirect cost per participant (Gillaizeau et al.,
2013). The insulin studies are as follows: Eight (80%) strictly evaluated patients admitted
into the intensive care unit with hyperglycemia, six of the studies included those
undergoing cardiac surgery, and two were patients in the critical care setting that were
critically ill. Only one study included a patient with type 2 diabetes mellitus. A computer
decision support system was integrated into healthcare systems EHR systems. Model
Predictive Control (MPC) was the software that was integrated. This software
incorporated an algorithm that aided in glucose management (Gillaizeau et al., 2013).
This software generates time for the next glucose intervention with set intervals of 0.5 to
4 hours (Gillaizeau et al., 2013). The six studies were a part of a closed loop insulin
infusion for critically ill patients. This system was integrated by the European which
wants to obtain a tighter glucose control for intensive care unit patients (Gillaizeau et al.,
2013). Three other studies utilized another software called Karlsburg Diabetes
Management System (KADIS), EndoTool Glucose Management System, GIN Computer
Software, and one other study utilized a weight-based insulin dose calculator (Gillaizeau
et al., 2013).
In the ten insulin studies, the effects differed between studies and the statistical
heterogeneity which determines a problem when conducting a meta- analysis was
elevated at 83% (Gillaizeau et al., 2013). However, all studies were in favor of
computerized assistance (Gillaizeau et al., 2013). In three of the studies there was no
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significant difference noted. The group showed favor of a computerized glucose
management system by SMD of 1.27, 95% to 1.98 (Gillaizeau et al., 2013). However,
there were noted inconsistencies because one study exhibited after a patient underwent
cardiac surgery and nine studies reported that the mean glucose level displayed a high
heterogeneity.
In the studies, a computer-based software was integrated into: healthcare
organizations electronic health record (EHR), laptop computers, smartphones, table
computers, or online calculators (Gillaizeau et al., 2013). In relation to insulin therapy
specifically, evidence did not exhibit any variance between mortality or any other clinical
unfavorable events. However, it was concluded by the researchers that computerized
advice for drug dosage can benefit people taking insulin compared to dosing where the
physician sets based on observation rather than computer assistance.
Nieuwlaat et al. (2011). Nieuwlaat et al. (2011), evidence level I quality level A
randomized control trial with meta-analysis, described different medications, the
therapeutic ranges associated with them, and the monitoring that is required for them.
The study examined how computerized clinical decision support systems (CCDSSs) have
the potential to ameliorate efficacy and safety of medication administration. A systematic
review was conducted and articles were retrieved from several different databases. These
databases include: MEDLINE, EMBASE, and Evidence-Based Medicine Reviews
(Nieuwlaat et al., 2011). There were 33 randomized controlled trials which assessed more
than glycemic control. It assessed computerized clinical decision support systems
(CCDSS) regarding: management vitamin K antagonists (14), insulin (6),
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theophylline/aminophylline (4), aminoglycosides (3), digoxin (2), lidocaine (1), or as part
of a multifaceted approach (3) (Nieuwlaat et al., 2011). The research question for this
systematic review was: do CCDSSs improve process of care or patient outcomes for
therapeutic drug monitoring and dosing (TDMD)? (Nieuwlaat et al., 2011). The study
selection included RCTs and the aim was to assess the effect of a CCDSS on care
measures, patient outcomes, the providing of dosing recommendations based on
individualized patient data placed into an integrated CCDSS (Nieuwlaat et al., 2011).
Data extracted consisted of a pair of reviewers that even attempted to contact the primary
authors of the studies via email to validate accuracy and to aid in filling the gap for
missing data (Nieuwlaat et al., 2011). There was a total of 25 out of 33 replies via email
back to the reviewers totaling 76% (Nieuwlaat et al., 2011).
The assessment of quality of all the RCTs for this study were scored for
methodological quality on a 10-point scale with 0 being the lowest quality level and 10
being the highest (Nieuwlaat et al., 2011). This scale was called the Jadad scale. The
CCDSS was considered effective with a (p<0.05) which mean they were of statistically
significance (Nieuwlaat et al., 2011). The database search rendered: n=14,794 that
screened potentially eligible, there was a total of n=14,188 eligible to be screened after
duplicates were removed, n=13,859 were excluded, n=329 articles were evaluated and
excluded because they were not full-text, n=163 articles with 74 being NCTs and 50 did
not evaluate CCDSS, 14 were only supplemental reports, 9 were deemed to have severe
methodological flaws, 7 did not meet the definition of a CCDSS, 4
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did not report outcomes that the author viewed as interesting, 4 had only the abstracts that
were published, 1 included a previous review studies, n=166 studies that were included in
the review met the TDMD criteria, n=33 (Nieuwlaat et al., 2011). In order for the CCDSS
to be deemed effective, patient outcomes much improve > 50% (Nieuwlaat et al., 2011).
As for data analysis and synthesis, CCDSS effectiveness was analyzed and a metaanalysis was performed in comparison of at least 2 studies to compare (Nieuwlaat et al.,
2011). The risk ratios were analyzed with a Review Manager. The possibility of bias was
assessed with a mismatch of clinicians and patients and was compared with the utilization
of a chi-square test (Nieuwlaat et al., 2011). The chi-square test did not find any
difference in process of care or patient outcomes (Pearson X2 evaluated the likelihood of
the difference in outcomes which equaled 1.12, 2p=0.29 or patient outcomes PX2=1.35,
2p=0.53 (Nieuwlaat et al., 2011). Likewise, the review exhibited that 18 out of the 30
studies did reveal improvement in the process of care and 4 of 19 (21%) displayed
improvement in patient outcomes (Nieuwlaat et al., 2011). Likewise, “all evaluable
studies assessing insulin dosing for glycemic control exhibited an improvement”
(Nieuwlaat et al., 2011, p. 13). It was concluded that decision makers at healthcare
organizations should contemplate and assess the possibility of a CCDSS. CCDSSs have
displayed how patient outcomes and the burden of cost can improve when it is
implemented.
Discussion of Findings in the Context of Framework
The Chronic Care Model (2017), was utilized as the theoretical framework for
this project. This model utilizes: the community, resources and policies, self-
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management, delivery system designs, health systems, organization of health care,
decision support, and clinical information systems (Improving Chronic Illness Care
Group Health Research, 2017). Each article addressed how resources and policies would
need to be changed in order to implement a computer-based glucose management system.
The articles explained how the delivery system design would have to be altered in order
improves outcomes. This could be done by steering from the traditional paper protocol to
a computer-based glucose management system. Each article discussed how computerbased glucose management software would integrate into the EHR, meaning clinical
information systems will be affected. Lastly, the model employs that self-management
support is imperative. This is accomplished through education and training. Please see
Appendix F for visual representation of the study findings and support and/or nonsupport of the utilization of CBGMS.
Recommendations
As healthcare organizations continue to advance in technology, it is critical for
leadership to take the initiative to research best practices and present it to upper
leadership (administration). This would aid in advocating for advancement within their
organizations information health systems. Furthermore, informatics leaders need to
conduct research. In doing so, these disciplines could aid in providing that support to
back the adoption of a computer-based glucose management system. Likewise, more
research needed to be conducted and published to exhibit the benefits of a computerbased glucose management system versus the traditional paper protocol. Also,
organizations need to develop a performance reporting system so that data can easily be
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extracted to measure performance and outcomes of inpatient diabetics. Additionally,
further research that demonstrates the cost implications for computer-based glucose
management systems in the inpatient setting is imperative. Lastly, this systematic review
illustrates the potential need for healthcare organizations to have an evidence-based
committee that are consistently researching and looking for ways to improve current
processes and provide care based on evidence of best practices.
Project Strengths and Limitations
Strengths
One of the major strengths of the systematic review is being able to
present the review to the DSC and the IDC at the practicum site. Being able to provide
the knowledge and research to support computer-based glucose management systems is a
plus for the practicum site. The practicum site sister facility already has this tool and
being able to present this systematic review will aid the site in presenting this information
to the appropriate party to push it forward.
Limitations
The main limitations of the systematic review were the lack of available
research sources available. There was not enough evidence to accurately come up with a
definite conclusion as to the evidence-based benefits of a computerized management
system. However, the evidence discovered did support the initiative to, at the minimum,
consider adopting a computer-based glucose management system in the inpatient care
setting. One must also consider the potential for bias and all the studies had to be
interpreted with great caution.
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Section 5: Dissemination Plan
Analysis of Self
Kavanoz and Yuksel (2016) identified the following skills one must possess to
become a scholar:
•

effective writing and oral communication skills to present one’s research,

•

the ability to think critically and outside the box,

•

the ability to argue one’s point when conducting research,

•

the ability to critically appraise and interpret literature and extract data,
and

•

skills to integrate and synthesize research.

Conducting this systematic review provided me with the opportunity to use all the skills
outlined by Kavanoz and Yuksel. I did so by identifying the research question, defining
the inclusion and exclusion criteria, searching for different studies on CBGMS,
deciphering and choosing studies based on the inclusion criteria, extracting data, and
evaluating the studies for bias. Dissemination of the systematic review will entail
presentation of the review to my practicum site’s DSC and the IDC. While working with
the IDC and serving as a member of the organization’s DSC, I discussed the possibility of
presenting the systematic review to these parties and gained feedback that this would be
more useful. Making the end-product of my project work a review would allow for my
findings and conclusions to be shared among key organizational stakeholders in their
entirety. Dissemination at the practicum organization is tentatively set for November 9,
2017, pending approval by my committee chair, co-chair, and URR member. My goal for
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the future is for this systematic review to be shared with the organization’s other
facilities.
As I reflect on all my courses and practicum experiences, I realize I have grown
significantly in relation to research. My courses and practicum experiences have given
me the ability to understand the concept of researching a topic or issue. For example, in
my current role as supervisor of day surgery and pre-assessment departments at my
organization, I confront many different issues. For example, when it comes to changing
current processes, I first go to the literature to see if there is evidence to support that
change.
Furthermore, my professional growth has enhanced tremendously in relation to
my leadership style and communication competence and capability. For example, I have
noticed that I do not possess just one type pf leadership style. My courses and practicum
experiences have enabled me to distinguish the type of leader I truly am. I now know that
my leadership style changes due to different circumstances or situations. For example,
there are times when I should be autocratic (e.g., when staffing or meeting the needs of
the unit), participative and/or democratic (e.g., in situations of shared governance, where
I always try to obtain input from the staff regardless of whether I am the final decision
maker or not), and transformational (e.g., by constantly communicating).
I decided to pursue my DNP degree for several reasons. One reason was to grow
as a leader. Without a doubt, my courses and practicum experiences have provided me
with opportunities to develop leadership skills. My practicum setting is one that is very
welcoming. My preceptor as well as the IDC I work with are also very welcoming and
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make me feel a part of their team. The DNP program at Walden University has also
taught me how to be a well-rounded scholarly nurse leader. I have adopted traits that I
admire from my preceptor and practicum site, and I have received recognition from my
own organization for doing so. I have been awarded the opportunity to be a part of
several committees at my practicum site. Some of these committees are the Ethics
Committee, Professional Development Committee, Performance Improvement
Committee, and the Diabetes Steering Committee. Being a part of these committees has
enabled me to be a welcoming voice and given me the opportunity to use the knowledge
and skills I have gained from my DNP courses, coursework, and project work.
Moreover, I have become competent in many areas. Some of the competencies I
have developed to aid in successful evidence-based project implementation, evaluation,
and dissemination are enhanced interpersonal skills, conflict resolution, time
management skills, organizational skills, enhanced cognitive skills, and critical thinking
skills. Likewise, my courses and practicum experience have given me the opportunity to
work on several different projects alongside my preceptor and the IDC. Working with the
IDC is very important to me, because my DNP project was centered on diabetes and
diabetes management. Working on many different projects at my practicum setting has
aided me in learning the different processes involved in disseminating information to the
staff; the role that education, quality, and executive leadership play in making
organizational changes; and how to prepare my doctoral finished product.
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Summary
Throughout the remainder of my professional career, I plan to continue to
collaborate with other leaders of the interdisciplinary team. As a leader, I will continue to
be engaged in many different committees in order to make changes in my organization as
well as in my community. I will continue to be exposed to different processes and
implementations at my current organization. Likewise, I will also collaborate with other
leaders at different organizations to gain knowledge on what works best for them and
what has not worked. For example, in working with the DMP throughout my practicum
experience, I found that there were constant changes being made to optimize the DMP; I
continuously worked to address these changes with my preceptor and the IDC. In
conclusion, I will also continue to be a part of the Performance Improvement Committee
within my own organization to aid in disseminating information when changes occur
within my organization and the community.
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Appendix A: Approval to Use Johns Hopkins Appraisal Tool

JOHNS HOPKINS
NURSING EVIDENCEBASED PRACTICE
MODEL AND TOOLS
Thank you for submitting the requested information. You now have permission to use the JHN
EBP model and tools.
Click here to download the tools. Reminder: You may not modify the model or the tools. All
reference to source forms should include “©The Johns Hopkins Hospital/The Johns Hopkins
University.”
We offer an excellent online course about our model/tools. It is an engaging online experience,
containing interactive elements, self-checks, instructional videos, and demonstrations of how to
put EBP into use. The course follows the EBP process from beginning to end and provides
guidance to the learner on how to proceed, using the tools that are part of the Johns Hopkins
Nursing EBP model. Take a sneak peek of the course.
Click here for more information about our online course. Group rates available,
email ijhn@jhmi.edu to inquire.
Do you prefer hands-on learning? We are offering a 5-day intensive Boot Camp where you will
learn and master the entire EBP process from beginning to end. Take advantage of our retreattype setting to focus on your project, collaborate with peers, and get the expertise and assistance
from our faculty. Click here to learn more about EBP Boot Camp.
Institute for Johns Hopkins Nursing
http://www.hopkinsmedicine.org/institute_nursing/
IJHN@jhmi.edu
443-287-4745
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Appendix B: Johns Hopkins Nursing Evidence-Based Practice Project Management
Guide
Initial EBP Question:
EBP Team Leader(s):
EBP Team Members:

Activities
PRACTICE QUESTION:

Start Date

Days
Required

End Date

Person
Assigned

Milestone

Comment / Resources
Required

Step 1: Recruit interprofessional
team
Step 2: Develop and refine the
EBP question
Step 3: Define the scope of the
EBP question and identify
stakeholders
Step 4: Determine responsibility
for project leadership
Step 5: Schedule team meetings

EVIDENCE:
Step 6: Conduct internal and
external search for evidence
Step 7: Appraise the level and
quality of each piece of evidence
Step 8: Summarize the individual
evidence
Step 9: Synthesize overall
strength and quality of evidence
Step 10: Develop
recommendations for change
based on evidence synthesis
Strong, compelling evidence,
consistent results
Good evidence, consistent
results
Good evidence, conflicting
results
Insufficient or absent evidence

TRANSLATION:
Step 11: Determine fit, feasibility,
and appropriateness of
recommendation(s) for translation
path
Step 12: Create action plan
Step 13: Secure support and
resources to implement action
plan
Step 14: Implement action plan
Step 15: Evaluate outcomes
Step 16: Report outcomes to
stakeholders
Step 17: Identify next steps
Step 18: Disseminate findings
© The Johns Hopkins Hospital/Johns Hopkins University. May not be used or reprinted without permission.

Adapted from John Hopkins Medicine Center for Evidence Based Practice. John
Hopkins Nursing Evidence-Based Practice Model. Retrieved April 27, 2017 from
http://www.hopkinsmedicine.org/evidence-basedpractice/_docs/appendix_a_proj_management_guide.pdf
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Appendix C: Johns Hopkins Nursing Evidence-Based Practice Question Development
Tool

Adapted from John Hopkins Medicine Center for Evidence Based Practice. John
Hopkins Nursing Evidence-Based Practice Model. Retrieved April 27, 2017 from
http://www.hopkinsmedicine.org/evidence-basedpractice/_docs/appendix_B_final.Question_Development_PICO.pdf.
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Appendix D: Johns Hopkins Nursing Evidence-Based Practice Evidence Level and
Quality Guide

Evidence Levels

Quality Guides

Level I
Experimental study, randomized controlled trial (RCT)
Systematic review of RCTs, with or without meta-analysis

A High quality: Consistent, generalizable results; sufficient sample size for the study
design; adequate control; definitive conclusions; consistent recommendations based
on comprehensive literature review that includes thorough reference to scientific
evidence

Level II
Quasi-experimental study
Systematic review of a combination of RCTs and quasiexperimental, or quasi-experimental studies only, with or without
meta-analysis
Level III
Non-experimental study
Systematic review of a combination of RCTs, quasi-experimental
and non-experimental studies, or non-experimental studies only,
with or without meta-analysis
Qualitative study or systematic review with or without a metasynthesis

B Good quality: Reasonably consistent results; sufficient sample size for the study
design; some control, fairly definitive conclusions; reasonably consistent
recommendations based on fairly comprehensive literature review that includes
some reference to scientific evidence
C Low quality or major flaws: Little evidence with inconsistent results; insufficient
sample size for the study design; conclusions cannot be drawn
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Adapted from John Hopkins Medicine Center for Evidence Based Practice. John Hopkins
Nursing Evidence-Based Practice Model. Retrieved April 27, 2017 from
http://www.hopkinsmedicine.org/evidence-basedpractice/_docs/appendix_c_evidence_level_quality_guide.pdf.
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Appendix E: Johns Hopkins Nursing Evidence-Based Practice Research Appraisal Tool

56

57
Quality Appraisal of Research Studies
•
•
•
•
•

•
•
•
•
•
•
•
•

Does the researcher identify what is known and not known about the problem and how the
study will address any gaps in knowledge?
Was the purpose of the study clearly presented?
Was the literature review current (most sources within last 5 years or classic)?
Was sample size sufficient based on study design and rationale?
If there is a control group:
o Were the characteristics and/or demographics similar in both the control and
intervention groups?
o If multiple settings were used, were the settings similar?
o Were all groups equally treated except for the intervention group(s)?
Are data collection methods described clearly?
Were the instruments reliable (Cronbach's α [alpha] > 0.70)?
Was instrument validity discussed?
If surveys/questionnaires were used, was the response rate > 25%?
Were the results presented clearly?
If tables were presented, was the narrative consistent with the table content?
Were study limitations identified and addressed?
Were conclusions based on results?

Yes
Yes
Yes
Yes

No
No
No
No

Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes

No
No
No
No
No
No
No
No
No
No
No

NA
NA
NA
NA
NA
NA
NA

Quality Appraisal of Systematic Review with or without Meta-Analysis or Meta-Synthesis
•
•

•
•
•
•
•

Was the purpose of the systematic review clearly stated?
Were reports comprehensive, with reproducible search strategy?
o Key search terms stated
o Multiple databases searched and identified
o Inclusion and exclusion criteria stated
Was there a flow diagram showing the number of studies eliminated at each level of
review?
Were details of included studies presented (design, sample, methods, results, outcomes,
strengths and limitations)?
Were methods for appraising the strength of evidence (level and quality) described?
Were conclusions based on results?
o Results were interpreted
o Conclusions flowed logically from the interpretation and systematic review question
Did the systematic review include both a section addressing limitations and how they were
addressed?

Yes
Yes
Yes
Yes
Yes

No
No
No
No
No

Yes

No

Yes
Yes
Yes
Yes
Yes

No
No
No
No
No

Yes

No
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Quality Rating Based on quality appraisal
A High quality: consistent, generalizable results; sufficient sample size for the study design;
adequate control; definitive conclusions; consistent recommendations based on comprehensive
literature review that includes thorough reference to scientific evidence
B Good quality: reasonably consistent results; sufficient sample size for the study design; some
control, and fairly definitive conclusions; reasonably consistent recommendations based on fairly
comprehensive literature review that includes some reference to scientific evidence
C Low quality or major flaws: little evidence with inconsistent results; insufficient sample size for
the study design; conclusions cannot be drawn

Adapted from John Hopkins Medicine Center for Evidence Based Practice. John
Hopkins Nursing Evidence-Based Practice Model. Retrieved April 27, 2017 from
http://www.hopkinsmedicine.org/evidence-based
practice/_docs/Appendix%20E%20image.jpg.
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Appendix F: Johns Hopkins Nursing Evidence-Based Individual Evidence Summary
Tool/Table

EBP Question: what is the current evidence supporting the utilization of a
computer-based glucose management system for inpatient diabetic adults in the
acute and critical care settings?

Date:
Article
#

1

Author &
Date

Evidence
Type

Fillmore, C.
L., Bray, B.
E., &
Kawamoto,
K. (2013).

RCT,
Systematic
Review
with metaanalysis

Sample,
Sample Size &
Setting
7,663 articles,
78 manuscripts
were included.
In a general
hospital setting.
MEDLINE
Database
utilized to
retrieve
studies.

Study findings that help
answer the EBP question

Limitations

The findings in this
systematic review exhibit that
clinical decision support
(CDS) systems aids as an
optimizing approach to
ameliorate care and reduce
cost in the inpatient care
setting. Encouraged to
support CDS and inpatient
care cost.

Data
search was
limited to
only one
database
MEDLINE
Extracting
data from
more than
one source
could aid in
a more
inclusive
search and
more data
can be
extracted.

All types of study designs that
met Effective Practice and
Organization of Care Group
(EPOC) inclusion criteria was
utilized. These include:
randomized controlled trials
(RCTs), non-randomized
controlled trials (NRCTs),
controlled before-and-after
(CBA), and interrupted time
series (ITS) studies. The
participants were healthcare
professionals with
responsibility for patient care.
It was concluded by the
researchers that
computerized advice for drug

The
sample size
could be
greater to
support the
qualitative
research.
Risk for
bias was
noted even
with the
EPOC
checklist.

N/A

2

Gillaizeau,
F., Chan, E.,
Tringuart, L.,
Colombet, I.,
Waton, R.
T., RegeWalther, M.,
Burnand, B.,
& Durieux,
P. (2013).

RCT,
Systematic
Review
with metaanalysis

42 trials (40
randomized
controlled trials
(trials that
allocate people
at random to
receive one of
a number of
drugs or
procedures)
and two nonrandomized
controlled
trials). Data
was extracted
from scientific
databases.

Evidence
Level &
Quality
Level 1
Quality B

Level 1
Quality A
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Article
#

Author &
Date

Evidence
Type

Sample,
Sample Size &
Setting
This was a
Systematic
Review.
N/A

3

Nieuwlaat,
R.,
Connolly, S.,
Mackay, J.
A., WeiseKelly, L.,
Navarro, T.,
Wilczynski,
N. L., &
Haynes, R.
B. (2011).

RCT,
Systematic
review with
metaanalysis

Thirty-three
randomized
controlled trials.

A decision
maker
researcher
partnership
systematic
review was
conducted.
This review
included
studies from
new studies
and databases:
MEDLINE,
EmBASE,
EvidenceBased
Medicine
Reviews, and
Inspec.
N/A

Study findings that help
answer the EBP question

Limitations

Evidence
Level &
Quality

The
systematic
review
assessed
more than
glycemic
control. It
assessed
computeriz
ed clinical
decision
support
systems
(CCDSS)
regarding:
manageme
nt vitamin K
antagonists
(14), insulin
(6),
theophylline
/aminophylli
ne (4),
aminoglyco
sides (3),
digoxin (2),
lidocaine
(1), or as
part of a
multifacete
d approach
(3).
This made
it difficult to
extract the
data related
to glucose
manageme
nt.

Level 1
Quality A

dosage can benefit patients
taking insulin compared to
dosing where the physician
sets based on observation
rather than computer
assistance.
An overall 60% of the studies
exhibited improvement for
process care and patient
outcomes. Recommendations
were delivered at the time of
care. Recommended insulin
dosing and glucose control in
patients in the Intensive Care
Unit (ICU) was achieved and
ranged from a blood glucose
level of (60-140). There was
predicted glycemic risk that
reduced hypoglycemic
episodes.

Adapted from John Hopkins Medicine Center for Evidence Based Practice. John
Hopkins Nursing Evidence-Based Practice Model. Retrieved April 27, 2017 from
http://www.hopkinsmedicine.org/evidence-basedpractice/_docs/appendix_g_individual_evidence_summary_tool.pdf.
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Appendix G: Excluded Studies and Reason for Exclusion
1. Albisser, A. M. (2009). Technophobia, prescription checking and the future of
diabetes management. Diabetologia, 52(6), 1013-1018. doi:10.1007/500125-0091341-8
a. Reason for exclusion: observational study and non-control group to support
evidence presented.
2. Blair, D., Zamora, L. Brumbelow, R., and Mercer, L. (2012). Glucose
management “a must” computerized software systems help boost outcomes,
reduce cost. Nursing Management, 43(12), 10-12.
doi:10.1097/01.NUMA,0000423781.61161.91
a. Reason for exclusion: non-randomized trial, no control group, non-systematic
review, research ended in 2012 nothing current within the last 5 years.
3. Cavalcanti, A. B., Silva, E., Pereira, A. J., Caldeira-Filho, M., Almeida, F. F.,
Westphal, G. A., Beims, R., Fernandes, C. C., Correa, T. D., Gouvea, M. R., &
Eluf-Neto, J. (2009). A randomized control-trial comparing a computer-assisted
insulin infusion protocol with a strict and a conventional protocol for glucose
control in critically ill patients. Journal of Critical Care, 24(3), 371-378. doi:
https://doi.org/10.1016/j.jcrc.2009.05.005
a. Reason for exclusion: not a systematic review, was a RCT but only studied
167 patients in the Medical Intensive Care Unit, non-meta-analysis.
4. Crockett, S. E., Suarez-Cavelier, J., Accola, K. D., Hadas, L. A., Harnage, D. L.,
Garrett, P. R., Butler, K. A., & Mulla, Z. D. (2012). Risk of postoperative
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hypoglycemia in cardiovascular surgical patients receiving computer-based versus
paper-based insulin therapy. Endocrine Practice, 18(4), 529-537. doi:
10.4158/EP11337.OR
a. Reason for exclusion: observational study, non-systematic review, non-metaanalysis, non-RCTs, data analyzed with use of SAS software version 9.2.
Kaplan-Meier survival curves, Wilcoxon test, and Cox model were utilized to
provide statistical analysis. All were good analytic tools but there was not an
sufficient control group.
5. Dortch, M. J., Mowery, N. T., Ozdas, A., Dossett, L. Cao, H., Collier, B., Holdes,
G., Miller, R. A., & May, A. K. (2008). A computerized insulin infusion titration
protocol improves glucose control with less hypoglycemia compared to a manual
titration protocol in a trauma intensive care unit. Journal of Parenteral and
Enteral Nutrition, 32(1), 18-27. doi:https://doi.org/10.1177/014860710803200118
a. Reason for exclusion: a cohort study with 552 critically ill patients.
6. Eslami, S., Abu-Hanna, A., DeJonge, E., & DeKeizer, N., F. (2009). Tighter
glycemic control and computerized decision-support systems: a systematic
review. Intensive Care Medicine, 35(9), 1505-1517. doi:10.1007/s00134-0091542-0
a. Reason for exclusion: systematic review with only 3 RCTs, data extracted
from papers from 1950-2008.
7. Frits, G. W., Cleveringa, K. J., Gorter, M., Van Gijsel, J., & Guy-Rutten, E. H. M.
(2013). Computerized decision support systems in primary care for type 2
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diabetes patients only improve patients’ outcomes when combined with feedback
on performance and case management: a systematic review. Diabetes Technology
& Therapeutics, 15(2), 180-192. doi:https://doi.org/10.1089/dia.2012.0201
a. Reason for exclusion: this paper was a systematic review with meta-analysis
and RCTs, however this paper only discussed type 2 diabetes.
8. Harrison, R. L., Stalker, S. L., Henderson, R., & Lyerla, F. (2013). Use of a
clinical decision support system to improve hypoglycemia management.
MEDSURG Nursing, 22(4), 250-263.
a. Reason for exclusion: no control group, results were limited to one facility,
non-randomized trial, not a systematic review.
9. Huser, V., Rasmussen, L. V., Oberg, R., Starren, J. B. (2011). Implementation of
workflow engine technology to deliver basic clinical decision support
functionality. BMC Medical Research, 11(43), 1-19.
a. Reason for exclusion: paper did discuss clinical decision support systems but
there was no control-group to compare results. Non-systematic review, nonmeta-analysis, diabetes management was not specifically discussed. Objective
assessed utilizing clinical decision support systems, potential bias.
10. Kansagara, D., Fu R, F. M., Wolf, F. L., & Helfand, M. (2011). Intensive insulin
therapy in hospitalized patients: a systematic review. Annals of Internal Medicine,
154(4), 268-282.
a. Reason for exclusion: more related to insulin therapy and not tools to aid in
improving outcomes, inclusion criteria differ significantly to reviewers
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inclusion criteria: perioperative care, myocardial infarction, stroke or brain
injury settings.
11. Magee, M. C. (2012). Improving IV insulin administration in a community
hospital. Journal of Visualized Experiments, 64, e3705.
a. Reason for exclusion: objective assessed utilizing clinical decision support
systems non-systematic review, data limited by only one community hospital.
12. Mann, E. A., Allen, D. A., Serio-Melvin, M. L., Wolf, S. E., & Salinas, J. (2012).
Clinician satisfaction with computer decision support in the intensive care unit.
Dimensions Critical Care Nursing, 31(1), 31-36.
doi:10.1097/DCC.0b013e31823a5553
a. Reason for exclusion: data was collected by a written questionnaire to all
clinical staff. A 5-point Likert scale was utilized to measure clinical
satisfaction. Non-systematic, non-meta-analysis, non-RCTs, descriptive
analysis was conducted.
13. Mann, E. A., Jones, J. A., Wolf, S. E., & Wade, C. E. (2011). Computer decision
support software safely improves glycemic control in the burn intensive care unit:
a randomized controlled clinical study. Journal of Burn Care & Research, 32(2),
246-255. doi:10.1097/BCR.0b013e31820aaebf
a. Reason for exclusion: a prospective, paired randomization crossover trail was
utilized, non-systematic review, non-meta-analysis.
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14. Mould, D. R., D’ Haens, G., & Upton, R. N. (2016). Clinical decision support
tools: the evolution of a revolution. Clinical Pharmacology and Therapeutics,
99(4), 405-418.
a. Reason for exclusion: not a systematic review, non-randomized trial, objective
assessed the utilization of several clinical support systems non-specific to just
glucose management.
15. Saager, L., Collins, G. L., Burnside, B., Tymke, W. H., Zhang, L., Jacobsohn, E.,
& Avidan, M. (2008). A randomized study in diabetic patients undergoing cardiac
surgery comparing computer-guided glucose management with a standard sliding
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a. Reason for exclusion: research is more than 9 years its 10 years old, a
prospective randomized control trial, limited participants (n=40), nonsystematic review, only involved diabetic patients undergoing cardiac surgery,
subject characteristics did not match inclusion criteria: male, female, BMI,
hypertension, chronic heart failure, myocardial infarctions, chronic renal
failure, ejection fraction, oral insulin, length of diabetes, hemoglobin A1C
level, and pre-operative triglycerides.
16. Wan, Q., Makeham, M., Zwar, N. A., & Petche, S. (2012). Qualitative evaluation
of a diabetes electronic decision support tool: views of users. BMC Medical
Informatics and Decision Making, 12(61), 1-7. doi: https://doi.org/10.1186/14726947-12-61
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a. Reason for exclusion: not a systematic review, objective assessed the users
support of electronic decision support tools, did not present direct patient
results or outcomes, qualitative study but the study design included only
telephone interviews from general practitioners and practice nurses, was a
non-randomized study.
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Appendix H: Risk of Bias EPOC Checklist

Suggested risk of bias criteria for EPOC reviews
Risk of bias for studies with a separate control group
- Randomized trials
- Non-randomized trials
- Controlled before-after studies
Nine standard criteria are suggested for all randomized trials, non-randomized trials and
controlled before-after studies. Further information can be obtained from the Cochrane
handbook section on risk of bias.
Was the allocation sequence adequately generated?
Score “Low risk” if a random component in the sequence generation process is described
(e.g. Referring to a random number table). Score “High risk” when a nonrandom method
is used (e.g. performed by date of admission). Non-randomized trials and controlled
before-after studies should be scored “High risk”. Score “Unclear risk” if not specified in
the paper.
Was the allocation adequately concealed?
Score “Low risk” if the unit of allocation was by institution, team or professional and
allocation was performed on all units at the start of the study; or if the unit of allocation
was by patient or episode of care and there was some form of centralized randomization
scheme, an on-site computer system or sealed opaque envelopes were used. Controlled
before-after studies should be scored “High risk”. Score “Unclear risk” if not specified in
the paper.
Were baseline outcome measurements similar?1,2
Score “Low risk” if performance or patient outcomes were measured prior to the
intervention, and no important differences were present across study groups. In
randomized trials, score “Low risk” if imbalanced but appropriate adjusted analysis was
performed (e.g. Analysis of covariance). Score “High risk” if important differences were
1

If some primary outcomes were imbalanced at baseline, assessed blindly or affected by
missing data and others were not, each primary outcome can be scored separately.
2

If “Unclear risk” or “High risk”, but there is sufficient data in the paper to do an
adjusted analysis (e.g. Baseline adjustment analysis or Intention to treat analysis) the
criteria should be re scored as “Low risk”.
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present and not adjusted for in analysis. If randomized trials have no baseline measure of
outcome, score “Unclear risk”.
Were baseline characteristics similar?
Score “Low risk” if baseline characteristics of the study and control providers are
reported and similar. Score “Unclear risk” if it is not clear in the paper (e.g.
characteristics are mentioned in text but no data were presented). Score “High risk” if
there is no report of characteristics in text or tables or if there are differences between
control and intervention providers. Note that in some cases imbalance in patient
characteristics may be due to recruitment bias whereby the provider was responsible for
recruiting patients into the trial.
Were incomplete outcome data adequately addressed?1
Score “Low risk” if missing outcome measures were unlikely to bias the results (e.g. the
proportion of missing data was similar in the intervention and control groups or the
proportion of missing data was less than the effect size i.e. unlikely to overturn the study
result). Score “High risk” if missing outcome data was likely to bias the results. Score
“Unclear risk” if not specified in the paper (Do not assume 100% follow up unless stated
explicitly).
Was knowledge of the allocated interventions adequately prevented during the
study? 1
Score “Low risk” if the authors state explicitly that the primary outcome variables were
assessed blindly, or the outcomes are objective, e.g. length of hospital stay. Primary
outcomes are those variables that correspond to the primary hypothesis or question as
defined by the authors. Score “High risk” if the outcomes were not assessed blindly.
Score “Unclear risk” if not specified in the paper.
Was the study adequately protected against contamination?
Score “Low risk” if allocation was by community, institution or practice and it is unlikely
that the control group received the intervention. Score “High risk” if it is likely that the
control group received the intervention (e.g. if patients rather than professionals were
randomized). Score “Unclear risk” if professionals were allocated within a clinic or
practice and it is possible that communication between intervention and control
professionals could have occurred (e.g. physicians within practices were allocated to
intervention or control)
Was the study free from selective outcome reporting?
Score “Low risk” if there is no evidence that outcomes were selectively reported (e.g. all
relevant outcomes in the methods section are reported in the results section). Score “High
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risk” if some important outcomes are subsequently omitted from the results. Score
“Unclear risk” if not specified in the paper.
Was the study free from other risks of bias?
Score “Low risk” if there is no evidence of other risk of biases

Risk of bias for interrupted time series studies
Seven standard criteria are used for all interrupted time series studies. Further
information can be obtained from the Cochrane handbook section on Risk of Bias and
from the draft methods paper on risk of bias under the EPOC specific resources section of
the EPOC website.
Note: If the interrupted time series study has ignored secular (trend) changes and
performed a simple t-test of the pre-versus post intervention periods without further
justification, the study should not be included in the review unless reanalysis is possible.
Was the intervention independent of other changes?
Score “Low risk” if there are compelling arguments that the intervention occurred
independently of other changes over time and the outcome was not influenced by other
confounding variables/historic events during study period. If Events/variables identified,
note what they are. Score “High risk” if reported that intervention was not independent of
other changes in time.
Was the shape of the intervention effect pre-specified?
Score “Low risk” if point of analysis is the point of intervention OR a rational
explanation for the shape of intervention effect was given by the author(s). Where
appropriate, this should include an explanation if the point of analysis is NOT the point of
intervention. Score “High risk” if it is clear that the condition above is not met.
Was the intervention unlikely to affect data collection?
Score “Low risk” if reported that intervention itself was unlikely to affect data collection
(for example, sources and methods of data collection were the same before and after the
intervention); Score “High risk” if the intervention itself was likely to affect data
collection (for example, any change in source or method of data collection reported).
Was knowledge of the allocated interventions adequately prevented during the
study?3

3

If some primary outcomes were assessed blindly or affected by missing data and others
were not, each primary outcome can be scored separately.
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Score “Low risk” if the authors state explicitly that the primary outcome variables were
assessed blindly, or the outcomes are objective, e.g. length of hospital stay. Primary
outcomes are those variables that correspond to the primary hypothesis or question as
defined by the authors. Score “High risk” if the outcomes were not assessed blindly.
Score “Unclear risk” if not specified in the paper.
Were incomplete outcome data adequately addressed?3
Score “Low risk” if missing outcome measures were unlikely to bias the results (e.g. the
proportion of missing data was similar in the pre- and post-intervention periods or the
proportion of missing data was less than the effect size i.e. unlikely to overturn the study
result). Score “High risk” if missing outcome data was likely to bias the results. Score
“Unclear risk” if not specified in the paper (Do not assume 100% follow up unless stated
explicitly).
Was the study free from selective outcome reporting?
Score “Low risk” if there is no evidence that outcomes were selectively reported (e.g. all
relevant outcomes in the methods section are reported in the results section). Score “High
risk” if some important outcomes are subsequently omitted from the results. Score
“Unclear risk” if not specified in the paper.
Was the study free from other risks of bias?
Score “Low risk” if there is no evidence of other risk of biases.
e.g. should consider if seasonality is an issue (i.e. if January to June comprises the preintervention period and July to December the post, could the “seasons’ have caused a
spurious effect).
Adapted from: Cochrane Effective Practice and Organization of Care (EPOC). Suggested
risk of bias criteria for EPOC reviews. EPOC Resources for review authors, 2017.
Available at: http://epoc.cochrane.org/epoc-specific-resources-review-authors.
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Appendix I1: Figures

Figure I1: Chronic care model. Adapted from Improving Chronic Illness Care Group
Health Research Institute. (2017). The Chronic Care Model. Retrieved from
http://www.improvingchroniccare.org/index.php?p=The_Chronic_Care_Model&s=2.
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Appendix I2: Figures
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Figure I2: Adapted from John Hopkins Medicine Center for Evidence Based
Practice. John Hopkins Nursing Evidence-Based Practice Model. Retrieved April
27, 2017 from http://www.hopkinsmedicine.org/evidence-basedpractice/_docs/appendix_i_synthesis_evidence_guide.pdf.
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